Crescent Capital Consulting, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Crescent Capital Consulting, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2021$98,000
+18.1%
2,216
+1.0%
0.02%
+6.7%
Q3 2021$83,000
-8.8%
2,195
-4.9%
0.02%
-11.8%
Q2 2021$91,000
+7.1%
2,308
-4.4%
0.02%
-10.5%
Q1 2021$85,000
+14.9%
2,414
+19.9%
0.02%0.0%
Q4 2020$74,0002,0140.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders